Results From Argos Therapeutics' Arcelis™ Immunotherapy Phase 2 Study for ... - PR Newswire (press release) PDF Print
PR Newswire (press release)The study is an open-label Phase 2 trial that enrolled 25 patients with newly diagnosed metastatic clear cell RCC. Post-nephrectomy, subjects received

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.